In addition, the statistical results of the survival curve indicated that the survival period of patients with gastric cancer with high expression levels of TET1 or GPX4 was significantly lower than that in patients with low expression of these genes (Figure 6D). The gene discussed is GPX4; the disease is gastric cancer.